NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesSEC Filings About Yield10 Bioscience Stock (NASDAQ:YTEN) Get Yield10 Bioscience alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume78,164 shsMarket Capitalization$257 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Yield10 Bioscience, Inc. is an agricultural bioscience company focused on developing sustainable products from Camelina sativa, an oilseed crop. The company’s technology platform is designed to improve Camelina’s agronomic performance and enable the production of plant-based oils and other renewable materials. Yield10 has pursued Camelina varieties that can produce oils for applications including biofuels, animal feed, and nutritional products such as omega-3 fatty acids. Its research has also included the development of Camelina capable of producing polyhydroxyalkanoate (PHA), a biodegradable bioplastic material. The company has conducted research and field-development activities in North America, including the United States and Canada. Yield10 Bioscience was formerly known as Metabolix, Inc. and adopted its current name in 2017. Oliver Peoples has served as the company’s president and chief executive officer and has been associated with its biotechnology and plant-metabolic engineering programs.AI Generated. May Contain Errors. Read More Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. YTEN Stock News HeadlinesYield10 Bioscience (NASDAQ:YTEN) Stock Price Breaks Above 200 Day Moving Average - Should You Sell?September 26, 2026 | americanbankingnews.comYield10 Bioscience Files for Chapter 11 BankruptcyDecember 6, 2024 | tipranks.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 3 at 1:00 AM | Stansberry Research (Ad)Yield10 Bioscience (OTC:YTEN) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comYield10 Bioscience (OTC:YTEN) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comYield10 Bioscience, Inc.: Yield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deYield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 14, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comSee More Headlines YTEN Stock Analysis - Frequently Asked Questions How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its quarterly earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) EPS for the quarter, beating analysts' consensus estimates of ($15.60) by $3.84. The specialty chemicals company earned $0.09 million during the quarter, compared to the consensus estimate of $0.22 million. When did Yield10 Bioscience's stock split? Yield10 Bioscience's stock reverse split before market open on Friday, May 3rd 2024.The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), Kushco (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL). Company Calendar Last Earnings11/09/2021Today10/03/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Food Products Sub-IndustryAgricultural Products & Services Current SymbolNASDAQ:YTEN CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees30Year Founded1992Profitability EPS (Trailing Twelve Months)($26.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.45 million Net MarginsN/A Pretax Margin-1,693.60% Return on EquityN/A Return on Assets-296.08% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.16 Sales & Book Value Annual Sales$60 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($4.97) per share Price / BookN/AMiscellaneous Outstanding Shares734,000Free Float689,000Market Cap$257 thousand OptionableNot Optionable Beta1.48 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:YTEN) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Yield10 Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YTEN Stock Alerts